A Phase 1, Bio-equivalence Study of TAK-536 Pediatric Formulation

Summary

The purpose of this study is to evaluate the bio-equivalence of a single oral administration of TAK-536 pediatric formulation (granules) in comparison with a TAK-536 commercial formulation (tablet) in Japanese healthy adult male participants in an open label, 2-period, 2-treatment, cross-over design.

Timeline

Start

2017-02-10

Primary completion

2017-03-11

Completion

2017-03-11

Drugs

Indications

No indication recorded.